Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2015 (2015), Article ID 374352, 9 pages
http://dx.doi.org/10.1155/2015/374352
Review Article

Atrial Fibrillation in the Young: A Neurologist’s Nightmare

1Department of Cardiology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK
2Imperial College, London, UK

Received 28 August 2014; Revised 19 March 2015; Accepted 20 March 2015

Academic Editor: Mamede de Carvalho

Copyright © 2015 Nikhil Aggarwal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Mother Teresa now in fair condition, New Straits Times, 1992.
  2. Tony Blair's Heart. Lying in State, The Economist, 2003.
  3. M. E. Dallas, 8 High-Profile Athletes With Atrial Fibrillation, 2014, http://www.everydayhealth.com/heart-health-pictures/world-class-athletes-with-atrial-fibrillation.aspx#02.
  4. V. Vassiliou, “Novel oral anticoagulants for stroke prevention in atrial fibrillation,” in Atrial Fibrillation Causes, Diagnosis and Treatment Options, L. Cunha, Ed., pp. 275–293, 2014. View at Google Scholar
  5. R. Sankaranarayanan, G. Kirkwood, K. Dibb, and C. J. Garratt, “Comparison of atrial fibrillation in the young versus that in the elderly: a review,” Cardiology Research and Practice, vol. 2013, Article ID 976976, 16 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. D. Easton and D. G. Sherman, “Management of cerebral embolism of cardiac origin,” Stroke, vol. 11, no. 5, pp. 433–442, 1980. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Mallouppas and V. Vassiliou, “Anticoagulation for atrial fibrillation: is this the end of warfarin? Not just yet,” Journal of Angiology, vol. 2013, Article ID 874827, 7 pages, 2013. View at Publisher · View at Google Scholar
  8. P. Khairy and S. Nattel, “New insights into the mechanisms and management of atrial fibrillation,” Canadian Medical Association Journal, vol. 167, no. 9, pp. 1012–1020, 2002. View at Google Scholar · View at Scopus
  9. N. A. M. M. Maaijwee, L. C. A. Rutten-Jacobs, P. Schaapsmeerders, E. J. van Dijk, and F.-E. de Leeuw, “Ischaemic stroke in young adults: risk factors and long-term consequences,” Nature Reviews Neurology, vol. 10, pp. 315–325, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Schmitt, G. Duray, B. J. Gersh, and S. H. Hohnloser, “Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications,” European Heart Journal, vol. 30, no. 9, pp. 1038–1045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. E. P. Waktare, “Cardiology patient page. Atrial fibrillation,” Circulation, vol. 106, no. 1, pp. 14–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Chamberlain, S. K. Agarwal, A. R. Folsom et al., “Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study,” Heart Rhythm, vol. 8, no. 8, pp. 1160–1166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Sanak, M. Hutyra, M. Kral et al., “Atrial fibrillation in young ischemic stroke patients: an underestimated cause,” European Neurology, vol. 73, no. 3-4, pp. 158–163, 2015. View at Google Scholar
  14. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, A. J. Camm et al., “Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC),” European Heart Journal, vol. 31, no. 19, pp. 2369–2429, 2010. View at Publisher · View at Google Scholar
  15. T. Andersson, A. Magnuson, I.-L. Bryngelsson et al., “All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case-control study,” European Heart Journal, vol. 34, no. 14, pp. 1061–1067, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. L. Waldo, “Mechanisms of atrial fibrillation,” Journal of Cardiovascular Electrophysiology, vol. 14, supplement 12, pp. S267–S274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Allessie, P. A. Boyden, A. J. Camm et al., “Pathophysiology and prevention of atrial fibrillation,” Circulation, vol. 103, no. 5, pp. 769–777, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Haïssaguerre, P. Jaïs, D. C. Shah et al., “Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins,” The New England Journal of Medicine, vol. 339, no. 10, pp. 659–666, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Haïssaguerre, P. Jaïs, D. C. Shah et al., “Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci,” Circulation, vol. 101, no. 12, pp. 1409–1417, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M. A. Russo, and A. Maseri, “Histological substrate of atrial biopsies in patients with lone atrial fibrillation,” Circulation, vol. 96, no. 4, pp. 1180–1184, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Kottkamp, “Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy,” European Heart Journal, vol. 34, no. 35, pp. 2731–2738, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. K. Stiles, B. John, C. X. Wong et al., “Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the ‘second factor’,” Journal of the American College of Cardiology, vol. 53, no. 14, pp. 1182–1191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Wilhelm, “Atrial fibrillation in endurance athletes,” European Journal of Preventive Cardiology, vol. 21, no. 8, pp. 1040–1048, 2014. View at Publisher · View at Google Scholar
  24. B. A. Schoonderwoerd, M. D. Smit, L. Pen, and I. C. van Gelder, “New risk factors for atrial fibrillation: causes of ‘not-so-lone atrial fibrillation’,” Europace, vol. 10, no. 6, pp. 668–673, 2008. View at Publisher · View at Google Scholar
  25. J. Hoogsteen, G. Schep, N. M. Van Hemel, and E. E. Van Der Wall, “Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up,” Europace, vol. 6, no. 3, pp. 222–228, 2004. View at Publisher · View at Google Scholar
  26. A. E. Darby and J. P. DiMarco, “Management of atrial fibrillation in patients with structural heart disease,” Circulation, vol. 125, no. 7, pp. 945–957, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. J. V. McMurray and M. A. Pfeffer, “Heart failure,” The Lancet, vol. 365, no. 9474, pp. 1877–1889, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H.-W. Park, M. J. Shen, S.-F. Lin, M. C. Fishbein, L. S. Chen, and P.-S. Chen, “Neural mechanisms of atrial fibrillation,” Current Opinion in Cardiology, vol. 27, no. 1, pp. 24–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J. V. Jayachandran, H. J. Sih, W. Winkle, D. P. Zipes, G. D. Hutchins, and J. E. Olgin, “Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation,” Circulation, vol. 101, no. 10, pp. 1185–1191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Brignole, L. Gianfranchi, C. Menozzi et al., “Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation,” Journal of the American College of Cardiology, vol. 22, no. 4, pp. 1123–1129, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. K. P. Phillips, “Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data,” Journal of Atrial Fibrillation, vol. 6, no. 3, pp. 62–67, 2013. View at Google Scholar · View at Scopus
  32. O. Campuzano and R. Brugada, “Genetics of familial atrial fibrillation,” Europace, vol. 11, no. 10, pp. 1267–1271, 2009. View at Google Scholar
  33. N. Øyen, M. F. Ranthe, L. Carstensen et al., “Familial aggregation of lone atrial fibrillation in young persons,” Journal of the American College of Cardiology, vol. 60, no. 10, pp. 917–921, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. Genetics Home Reference, Familial Atrial Fibrillation, 2015, http://ghr.nlm.nih.gov/condition/familial-atrial-fibrillation.
  35. NHS Improvement, Atrial Fibrillation in Primary Care: Making an Impact on Stroke Prevention, 2009.
  36. J. L. Blackshear and J. A. Odell, “Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation,” The Annals of Thoracic Surgery, vol. 61, no. 2, pp. 755–759, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. M.-J. Cha, Y. D. Kim, H. S. Nam, J. Kim, D. H. Lee, and J. H. Heo, “Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2DS2-VASc scores,” European Journal of Neurology, vol. 19, no. 3, pp. 473–479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Shirani and J. Alaeddini, “Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: Implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography,” Cardiovascular Pathology, vol. 9, no. 2, pp. 95–101, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. Ferro, “Cardioembolic stroke: an update,” The Lancet Neurology, vol. 2, no. 3, pp. 177–188, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Chant and C. McCollum, “Stroke in young adults: the role of paradoxical embolism,” Thrombosis and Haemostasis, vol. 85, no. 1, pp. 22–29, 2001. View at Google Scholar · View at Scopus
  41. M. Mallouppas, V. Vassiliou, M. Goddard, B. Rana, and D. Braganza, “An unusual complication of hip surgery: paradoxical coronary embolism of foreign material as a cause of acute MI,” EuroIntervention, 2014. View at Publisher · View at Google Scholar
  42. C. Arquizan, J. Coste, P.-J. Touboul, and J.-L. Mas, “Is patent foramen ovale a family trait? A transcranial Doppler sonographic study,” Stroke, vol. 32, no. 7, pp. 1563–1566, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Miller, C. Griffin, J. Shah, A. Metha, and P. Sharma, “A young stroke: the need for vigilance,” Journal of the Royal Society of Medicine, vol. 99, no. 10, pp. 527–528, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. R. G. Hart, J. W. Foster, M. F. Luther, and M. C. Kanter, “Stroke in infective endocarditis,” Stroke, vol. 21, no. 5, pp. 695–700, 1990. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Falanga and M. Marchetti, “Thrombotic disease in the myeloproliferative neoplasms.,” Hematology, vol. 2012, no. 1, pp. 571–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. L. Kujovich, “Factor v Leiden thrombophilia,” Genetics in Medicine, vol. 13, no. 1, pp. 1–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Siniscalchi, A. Bonci, N. B. Mercuri et al., “Cocaine dependence and stroke: pathogenesis and management,” Current Neurovascular Research, vol. 12, no. 2, pp. 163–172, 2015. View at Google Scholar
  48. H. Bevan, K. Sharma, and W. Bradley, “Stroke in young adults,” Stroke, vol. 21, no. 3, pp. 382–386, 1990. View at Publisher · View at Google Scholar · View at Scopus
  49. Stroke, http://www.nhs.uk/Conditions/Stroke/Pages/Symptoms.aspx.
  50. N. D. Doolittle, “Clinical ethnography of lacunar stroke: implications for acute care,” The Journal of Neuroscience Nursing, vol. 23, no. 4, pp. 235–240, 1991. View at Publisher · View at Google Scholar · View at Scopus
  51. N. D. Doolittle, “The experience of recovery following lacunar stroke,” Rehabilitation Nursing, vol. 17, no. 3, pp. 122–125, 1992. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Naess and H. Nyland, “Poststroke fatigue and depression are related to mortality in young adults: a cohort study,” BMJ Open, vol. 3, no. 3, Article ID 002404, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. T. B. Hafsteinsdóttir and M. Grypdonck, “Being a stroke patient: a review of the literature,” Journal of Advanced Nursing, vol. 26, no. 3, pp. 580–588, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. J.-M. Bugnicourt, O. Hamy, S. Canaple, C. Lamy, and C. Legrand, “Impaired sexual activity in young ischaemic stroke patients: an observational study,” European Journal of Neurology, vol. 21, no. 1, pp. 140–146, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. G. Y. H. Lip, R. Nieuwlaat, R. Pisters, D. A. Lane, and H. J. G. M. Crijns, “Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation,” Chest, vol. 137, no. 2, pp. 263–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. D. A. Lane and G. Y. H. Lip, “Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation,” Circulation, vol. 126, no. 7, pp. 860–865, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Pisters, D. A. Lane, R. Nieuwlaat, C. B. De Vos, H. J. G. M. Crijns, and G. Y. H. Lip, “A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey,” Chest, vol. 138, no. 5, pp. 1093–1100, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. J. E. Atwood and G. W. Albers, “Anticoagulation and atrial fibrillation,” Herz, vol. 18, no. 1, pp. 27–38, 1993. View at Google Scholar · View at Scopus
  59. R. G. Hart, L. A. Pearce, and M. I. Aguilar, “Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation,” Annals of Internal Medicine, vol. 146, no. 12, pp. 857–867, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Miguel and M. Viana-Baptista, “Oral anticoagulants: where does the treating neurologist stand?” in Atrial Fibrillation Causes, Diagnosis and Treatment Options, L. Cunha, Ed., pp. 295–302, 2014. View at Google Scholar
  61. S. N. Connolly and D. N. Houston, “Dabigatran: an alternative to warfarin for reduction of stroke in AF?” Cardiology Today, 2010. View at Google Scholar
  62. H. Jneid, J. L. Anderson, R. S. Wright et al., “2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Journal of the American College of Cardiology, vol. 60, no. 7, pp. 645–681, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. S. J. Connolly, M. D. Ezekowitz, S. Yusuf et al., “Dabigatran versus warfarin in patients with atrial fibrillation,” The New England Journal of Medicine, vol. 361, no. 12, pp. 1139–1151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. M. R. Patel, K. W. Mahaffey, J. Garg et al., “Rivaroxaban versus warfarin in nonvalvular atrial fibrillation,” The New England Journal of Medicine, vol. 365, no. 10, pp. 883–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. K. L. Furie, L. B. Goldstein, G. W. Albers et al., “Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American heart association/American stroke association,” Stroke, vol. 43, no. 12, pp. 3442–3453, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. C. van Walraven, R. G. Hart, D. E. Singer et al., “Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis,” The Journal of the American Medical Association, vol. 288, no. 19, pp. 2441–2448, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham, “Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies,” Mayo Clinic Proceedings, vol. 84, no. 7, pp. 643–662, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. D. G. Wyse, A. L. Waldo, J. P. DiMarco et al., “A comparison of rate control and rhythm control in patients with atrial fibrillation,” The New England Journal of Medicine, vol. 347, no. 23, pp. 1825–1833, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. K. R. J. Chun, B. Schmidt, K.-H. Kuck et al., “Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry,” Clinical Research in Cardiology, vol. 102, no. 6, pp. 459–468, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. T. J. Bunch and M. J. Cutler, “Is pulmonary vein isolation still the cornerstone in atrial fibrillation ablation?” Journal of Thoracic Disease, vol. 7, no. 2, pp. 132–141, 2015. View at Publisher · View at Google Scholar
  71. I. S. W. Party, National Clinical Guideline for Stroke, 2008.
  72. P. Sandercock, J. M. Wardlaw, R. I. Lindley et al., “The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial,” The Lancet, vol. 379, no. 9834, pp. 2352–2363, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Finsterer, “Management of cryptogenic stroke,” Acta Neurologica Belgica, vol. 110, no. 2, pp. 135–147, 2010. View at Google Scholar · View at Scopus
  74. F. Knebel, F. Masuhr, W. von Hausen et al., “Transesophageal echocardiography in patients with cryptogenic cerebral ischemia,” Cardiovascular Ultrasound, vol. 7, no. 1, article 15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. P. T. Ellinor, D. M. Yoerger, J. N. Ruskin, and C. A. MacRae, “Familial aggregation in lone atrial fibrillation,” Human Genetics, vol. 118, no. 2, pp. 179–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. D. Darbar, K. J. Herron, J. D. Ballew et al., “Familial atrial fibrillation is a genetically heterogeneous disorder,” Journal of the American College of Cardiology, vol. 41, no. 12, pp. 2185–2192, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. M. F. Sinner, N. R. Tucker, K. L. Lunetta et al., “Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation,” Circulation, vol. 130, no. 15, pp. 1225–1235, 2014. View at Publisher · View at Google Scholar
  78. L. Djoussé, D. Levy, E. J. Benjamin et al., “Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study,” The American Journal of Cardiology, vol. 93, no. 6, pp. 710–713, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. S. R. Lowenstein, P. A. Gabow, J. Cramer, P. B. Oliva, and K. Ratner, “The role of alcohol in new-onset atrial fibrillation,” Archives of Internal Medicine, vol. 143, no. 10, pp. 1882–1885, 1983. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Leonardi and J. Bissett, “Prevention of atrial fibrillation,” Current Opinion in Cardiology, vol. 20, no. 5, pp. 417–423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. J. Karjalainen, U. M. Kujala, J. Kaprio, S. Sarna, and M. Viitasalo, “Lone atrial fibrillation in vigorously exercising middle aged men: case-control study,” British Medical Journal, vol. 316, no. 7147, pp. 1784–1785, 1998. View at Google Scholar · View at Scopus
  82. S. Stortecky, B. R. da Costa, H. P. Mattle et al., “Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis,” European Heart Journal, vol. 36, no. 2, pp. 120–128, 2015. View at Publisher · View at Google Scholar
  83. P. A. Calvert, B. S. Rana, A. C. Kydd, and L. M. Shapiro, “Patent foramen ovale: anatomy, outcomes, and closure,” Nature Reviews Cardiology, vol. 8, no. 3, pp. 148–160, 2011. View at Publisher · View at Google Scholar · View at Scopus